Long-Term Opioid Efficacy Act of 2018
This bill expands the authority of the Food and Drug Administration (FDA)to require post-approval studies or clinical trials with respect to controlled substances (e.g., opioids).
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.